Two primary, promising drugs for pancreatic cancer are being developed by Revolution Medicines and a partnership between BioNTech and Genentech. These treatments, [daraxonrasib] and an mRNA vaccine, have shown significant potential in improving survival rates for patients with advanced disease.
These developments are being hailed as potential "practice-changing" outcomes for a disease that has historically had few effective treatment options.
Two New Drugs Offer Hope for Pancreatic Cancer
byu/Guy_PCS ininvesting
Posted by Guy_PCS